BCPC Overview

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Wall Street analysts forecast BCPC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BCPC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Balchem Corp revenue for the last quarter amounts to 263.62M USD, increased 9.84

Balchem Corp. EPS for the last quarter amounts to 1.21 USD, increased 18.63

Balchem Corp (BCPC) has 1352 emplpoyees as of March 25 2026.

Today BCPC has the market capitalization of 5.31B USD.